S&S Healthcare Holding Ltd. (4198.TWO)
TWD 31.5
(0.0%)
TWD 31.5
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -68.09 Million | -72.9 Million | -70.52 Million | -58.62 Million | - |
| Net Income | 102.85 Million | -70.37 Million | -95.39 Million | -114.81 Million | - |
| Depreciation & Amortization | 25.71 Million | 34.39 Million | 22.01 Million | 19.41 Million | - |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - |
| Change in working capital | -39.31 Million | -31.5 Million | -11.77 Million | 27.44 Million | - |
| Other non-cash items | 29.8 Million | -12.71 Million | 16.71 Million | 8.72 Million | - |
| Investing Cash Flow | 181.95 Million | -82.25 Million | -9.25 Million | -11.17 Million | - |
| Investments in PPE | -31.14 Million | -69.16 Million | -9.83 Million | -9.75 Million | - |
| Acquisitions | 407 Thousand | -20.98 Million | - | - | - |
| Investment purchases | - | - | - | - | - |
| Sales/Maturities of investments | 215.11 Million | - | - | - | - |
| Other Investing Activities | -3.67 Million | 6.45 Million | 584 Thousand | -1.42 Million | - |
| Financing Cash Flow | -29.59 Million | 149.97 Million | 112.47 Million | 88.87 Million | - |
| Debt repayment | -109.89 Million | -4.27 Million | -1.53 Million | -9.06 Million | - |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | 60 Million | 154.5 Million | 81.75 Million | 87.17 Million | - |
| Other Financing Activities | 24.92 Million | 5.1 Million | 39.2 Million | - | - |
| Accounts receivables | -21.84 Million | - | - | - | - |
| Accounts payables | -34.07 Million | - | - | - | - |
| Inventory | 14.93 Million | -53.77 Million | 8.72 Million | 17.19 Million | - |
| Other working capital | -32.4 Million | - | - | - | - |
| Cash at beginning of period | 112.32 Million | 121.87 Million | 94.68 Million | 73.59 Million | - |
| Cash at end of period | 198.98 Million | 112.32 Million | 121.87 Million | 94.68 Million | - |
| Capital Expenditure | -31.14 Million | -69.16 Million | -9.83 Million | -9.75 Million | - |
| Effect of forex changes on cash | 2.4 Million | -4.36 Million | -5.49 Million | 2.01 Million | - |
| Net cash flow / Change in cash | 86.66 Million | -9.55 Million | 27.19 Million | 21.08 Million | - |
| Free Cash Flow | -99.24 Million | -142.07 Million | -80.36 Million | -68.37 Million | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -14.23 Million | -17.73 Million | 102.85 Million | 150.86 Million | -6.46 Million | -28.16 Million |
| Depreciation & Amortization | 7.04 Million | 6.87 Million | 25.71 Million | 3.05 Million | 6.82 Million | 7.74 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -17.91 Million | -31.85 Million | -39.31 Million | 664 Thousand | -20.24 Million | 361 Thousand |
| Other non-cash items | -1.49 Million | 921 Thousand | 29.8 Million | 23.64 Million | -2.82 Million | 8.64 Million |
| Investing Cash Flow | -2.94 Million | -3.13 Million | 181.95 Million | 206.31 Million | -6.63 Million | -11.59 Million |
| Investments in PPE | -2.16 Million | -4.37 Million | -31.14 Million | -11.18 Million | -7.1 Million | -5.3 Million |
| Acquisitions | -3.13 Million | - | 407 Thousand | - | 407 Thousand | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -789 Thousand | 951 Thousand | -3.67 Million | 1.65 Million | -449 Thousand | -6.29 Million |
| Financing Cash Flow | -5.8 Million | 13.15 Million | -29.59 Million | -101.6 Million | 37.58 Million | 36.94 Million |
| Debt repayment | -1.21 Million | -7.18 Million | -109.89 Million | -104.79 Million | -2.02 Million | -1.73 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 60 Million | - | 30 Million | - |
| Other Financing Activities | -3.04 Million | 7.5 Million | 24.92 Million | 4.4 Million | 10.69 Million | - |
| Accounts receivables | -1.62 Million | - | - | - | - | - |
| Accounts payables | 6.37 Million | - | - | - | - | - |
| Inventory | -8.93 Million | 349 Thousand | 14.93 Million | 7.86 Million | 6.74 Million | -7.12 Million |
| Other working capital | -13.93 Million | - | - | - | - | - |
| Cash at beginning of period | 165.27 Million | 198.98 Million | 112.32 Million | 99.65 Million | 93.82 Million | 78.85 Million |
| Cash at end of period | 126.75 Million | 165.27 Million | 198.98 Million | 198.98 Million | 99.65 Million | 93.82 Million |
| Capital Expenditure | -2.16 Million | -4.37 Million | -31.14 Million | -11.18 Million | -7.1 Million | -5.3 Million |
| Effect of forex changes on cash | 398 Thousand | -1.94 Million | 2.4 Million | 4.49 Million | -861 Thousand | -1.04 Million |
| Net cash flow / Change in cash | -38.51 Million | -33.71 Million | 86.66 Million | 99.33 Million | 5.82 Million | 14.97 Million |
| Free Cash Flow | -32.33 Million | -46.16 Million | -99.24 Million | -21.05 Million | -31.36 Million | -14.63 Million |
8097
2326
6486
HBIA
RED
6426